Mirae Asset Life Insurance Introduces "Carbon Ion Cancer Therapy Agency Service" via Its App

Mirae Asset Life Insurance announced on December 1 that it has newly introduced a "Carbon Ion Cancer Therapy Agency Service" to its "M-LIFE" application digital healthcare service.

Carbon ion therapy is a next-generation cancer treatment technology. It is an advanced radiation therapy that utilizes the physical properties of carbon ions to precisely target cancer cells while minimizing damage to healthy tissues.

This new service has been available since last month and can be used by any healthcare member with an Orange grade or higher (with a monthly protection-type premium of at least 50,000 won), regardless of whether they have subscribed to a specific product rider. Mirae Asset Life Insurance's new service works in partnership with seven specialized carbon ion therapy hospitals in Japan to mediate optimized medical support for patients with solid tumors that are difficult to treat domestically.

A concierge service linked to local hospitals in Japan is also provided. This service offers comprehensive support throughout the entire process, including guidance on round-trip airfare, accommodation during treatment, meals, vehicle escort, and professional medical interpretation. Users of the concierge service receive a 10% preferential discount on accommodation costs and free benefits for the advance preparation process (such as registration and translation).

Choi Jinhyuk, Head of the Digital Division at Mirae Asset Life Insurance, stated, "With advances in cutting-edge medical technology, the latest cancer treatment options available to customers are steadily expanding," adding, "We will continue to strengthen our differentiated, customized digital healthcare services with customer health as our top priority."

This content was produced with the assistance of AI translation services.